239 related articles for article (PubMed ID: 27513212)
1. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
3. Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase.
Khalid H; Ashfaq UA
Comb Chem High Throughput Screen; 2022; 25(2):335-346. PubMed ID: 33371844
[TBL] [Abstract][Full Text] [Related]
4. Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus.
Mustafa G; Majid M; Ghaffar A; Yameen M; Samad HA; Mahrosh HS
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2317-2322. PubMed ID: 33832906
[TBL] [Abstract][Full Text] [Related]
5. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
[TBL] [Abstract][Full Text] [Related]
6. Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study.
Elfiky AA
Med Chem; 2019; 15(2):130-137. PubMed ID: 30324891
[TBL] [Abstract][Full Text] [Related]
7. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel natural flavonoids as potent antiviral candidates against hepatitis C virus NS5B polymerase.
Akher FB; Farrokhzadeh A; Ramharack P; Shunmugam L; Van Heerden FR; Soliman MES
Med Hypotheses; 2019 Nov; 132():109359. PubMed ID: 31466018
[TBL] [Abstract][Full Text] [Related]
9. Characterization of
Shahid I; Almalki WH; Ibrahim MM; Alghamdi SA; Mukhtar MH; Almalki SSR; Alkahtani SA; Alhaidari MS
Indian J Med Microbiol; 2018; 36(4):494-503. PubMed ID: 30880695
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from
Patil VS; Harish DR; Vetrivel U; Roy S; Deshpande SH; Hegde HV
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164341
[No Abstract] [Full Text] [Related]
11. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.
Ravikumar YS; Ray U; Nandhitha M; Perween A; Raja Naika H; Khanna N; Das S
Virus Res; 2011 Jun; 158(1-2):89-97. PubMed ID: 21440018
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel Hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase.
Khalid H; Landry KB; Ijaz B; Ashfaq UA; Ahmed M; Kanwal A; Froeyen M; Mirza MU
Infect Genet Evol; 2020 Oct; 84():104371. PubMed ID: 32485331
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors.
Mirza MU; Ghori NU; Ikram N; Adil AR; Manzoor S
Drug Des Devel Ther; 2015; 9():1825-41. PubMed ID: 25848219
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
Hassan GS; Georgey HH; Mohammed EZ; Omar FA
Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
[TBL] [Abstract][Full Text] [Related]
15. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
Tarannum H; Nandi S
Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential anti-hepatitis C virus agents targeting non structural protein 5B using computational techniques.
Polamreddy P; Vishwakarma V; Saxena P
J Cell Biochem; 2018 Nov; 119(10):8574-8587. PubMed ID: 30058078
[TBL] [Abstract][Full Text] [Related]
17. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.
Harikishore A; Li E; Lee JJ; Cho NJ; Yoon HS
Mol Divers; 2015 Aug; 19(3):529-39. PubMed ID: 25862642
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
[TBL] [Abstract][Full Text] [Related]
19. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase.
Manfroni G; Meschini F; Barreca ML; Leyssen P; Samuele A; Iraci N; Sabatini S; Massari S; Maga G; Neyts J; Cecchetti V
Bioorg Med Chem; 2012 Jan; 20(2):866-76. PubMed ID: 22197397
[TBL] [Abstract][Full Text] [Related]
20. Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro.
Flores-Ocelotl MR; Rosas-Murrieta NH; Moreno DA; Vallejo-Ruiz V; Reyes-Leyva J; Domínguez F; Santos-López G
BMC Complement Altern Med; 2018 Mar; 18(1):95. PubMed ID: 29548293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
